Urinary tissue factor levels in patients with breast and colorectal cancer

Journal of Pathology

Volumn 187, Issue 3, 1999, Pages 291-294

  Lwaleed, Bashir A ^a,c   Chisholm, Morag ^a   Francis, John L ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b FLORIDA HOSPITAL   (United States)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cancer; Coagulopathy; Urinary tissue factor

Indexed keywords

THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; BREAST CANCER; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST DISEASES; BREAST NEOPLASMS; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KIDNEY CALCULI; MALE; MIDDLE AGED; NEOPLASM PROTEINS; SURVIVAL RATE; THROMBOPLASTIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0032953972     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199902)187:3<291::AID-PATH213>3.0.CO;2-8     Document Type: Article

References (28)

1. Rodgers GM. Haemostatic properties of normal and perturbed vascular cells. FASEB J 1988; 2: 116-123.
2. Cybulsky MI, Chan MKW, Movat HZ. Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumour necrosis factor and their implications in Gram-negative infection. Lab Invest 1988; 58: 365-378.
3. Grunke W. Studien über die Bluterinnung mit besonderer Berücksichtigung der Haemophilie I. Mitteilung: Einfluss des Harnes auf die Gerinnung haemophilen Blutes. Blutes Z Ces Exp Med 1835; 96: 512-516.
4. Tocantins LM, Lindquist JN. Thromboplastic activity of the urine. Proc Soc Exp Biol NY 1947; 65: 44-49.
5. von Kaulla KN. Extraction and concentration of thromboplastic material from human urine. Proc Soc Exp Biol Med NY 1956; 91: 543-545.
6. Wiggins R, Glatfelter A, Kshirsagar B, Beals T. Lipid vesicles and their association with procoagulant activity and glomeruli of rabbits with nephrotoxic nephritis. Lab Invest 1987; 56: 264-272.
7. Carty N, Taylor I, Roath OS, El-Baruni K, Francis JL. Urinary tissue factor activity in malignancy. Thromb Res 1990; 57: 473-478.
8. Carty N, Taylor I, Roath OS, El-Baruni K, Francis JL. Urinary tissue factor activity in colorectal disease. Br J Surg 1990; 77: 1091-1094.
9. Bach RR, Nemrson Y, Konigsberg WK. Purification and characterization of bovine tissue factor. J Biol Chem 1981; 256: 8324-8331.
10. Guha A, Bach RR, Konigsberg W, Nemerson Y. Affinity purification of human tissue factor. Interaction of Factor VII and tissue factor in detergents micelles. Proc Natl Acad Sci USA 1986; 83: 299-302.
11. Nemerson Y, Bach R. Tissue factor revisited. Prog Hemost Thromb 1982; 6: 237-261.
12. Nemerson Y. The tissue factor pathway of blood coagulation. Semin Haemost 1992; 29: 170-176.
13. Adamson AS, Francis JL, Roath OS, Witherow RO'N, Snell ME. Urinary tissue factor levels in transitional cell carcinoma of the bladder. J Urol 1992; 148: 449-452.
14. Adamson AS, Francis JL, Witherow RO'N, Snell ME. Urinary tissue factor levels in prostatic carcinoma: a potential marker of metastatic spread. Br J Urol 1993; 71: 587-592.
15. Lwaleed BA, Bass PS, Chisholm M, Francis JL. Urinary tissue factor levels in glomerulonephritis: a potential marker of glomerular injury. J Clin Pathol 1997; 50: 336-340.
16. Carson SD, Konigsberg WH. Cadmium increased tissue factor (coagulation factor III) activity by facilitating its reassociation with lipids. Science 1980; 208: 307-309.
17. Mundy AR. Urinary hydroxyproline excretion in carcinoma of the prostate: a comparison of 4 different modes of assessment and its role as a marker. Br J Urol 1979; 51: 570-574.
18. Wajsman Z, Merrin CE, Chu MT, Moore RH, Murphy GB. Evaluation of biological markers in bladder cancer. J Urol 1975; 114: 879-883.
19. Martinez-Pinerio JA, Pertusac C, Maganto E, et al. Urinary fibrinogen degradation products (FDP) in bladder cancer. Eur Urol 1978; 4: 348-350.
20. Spillert CR, Lazaro EJ. Shortened endotoxin-activated clotting time in patients with carcinoma. Am Surg 1987; 53: 164-166.
21. Osterud B, Olsen JO, Wilsgard L. The role of arachidonic acid release and lipoxygenase pathway in lipopolysaccharide-induced thromboplastin activity in monocytes. Blood Coagul Fibrinol 1990; 1: 41-46.
22. Dasmahapatra KS, Cheung NK, Spillert C, Lazaro E. An assessment of monocytes' procoagulant activity in patients with solid tumours. J Surg Res 1987; 43: 158-163.
23. Contrino J, Hair G, Kreutzer D, Rickles FR. In situ detection of expression of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast tissue. Nature Med 1996; 2: 209-215.
24. Edwards RL, Levine JB, Green R. et al. Activation of blood coagulation in Crohn's disease: increased fibrinopeptide A levels and enhanced generation of monocytes' tissue factor activity. Gastroenterology 1987; 92: 329-337.
25. Lwaleed BA, Bass PS, Rogerson ME, Francis JL, Chisholm M. Effect of kidney function and disease status on urinary tissue factor measurements. J Clin Pathol 1998; 51: 234-237.
26. Szczepanski M, Bardadin K, Zawadzki J, Pypno W. Procoagulant activity of gastric, colorectal and renal-cancer is Factor-VII-dependent. J Cancer Res Clin Oncol 1988; 114: 519-522.
27. El-Baruni K. Factor X-activating procoagulant in normal and malignant breast tumour. Ph.D. thesis. Southampton University, 1990.
28. Murray JC. Coagulation and cancer. Br J Cancer 1991; 64: 422-424.